Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Ibipinabant
Cat. No.:
OB0425LY-162
Appearance:
Solid
Purity:
99.9%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Ibipinabant is a specific CB1 receptor antagonist that helps regulate appetite and energy metabolism.
Synonyms:
464213-10-3; SLV319; BMS-646256; SLV-319; (4S)-5-(4-Chlorophenyl)-N-(4-chlorophenyl)sulfonyl-N'-methyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide; 3-(4-Chlorophenyl)-N-((4-chlorophenyl)sulfonyl)-4,5-dihydro-N'-methyl-4-phenyl-1H-pyrazole-1-carboximidamide; (4S)-3-(4-Chlorophenyl)-N-(4-chlorophenyl)sulfonyl-N'-methyl-4-phenyl-4,5-dihydropyrazole-1-carboximidamide
CAS No.:
464213-10-3
Compound CID:
9826744
Formula:
C23H20Cl2N4O2S
Formula Weight:
487.4
Specification
Target:
Cannabinoid receptor
Pathway:
GPCR/G protein; Neuronal signaling; MAPK/ERK pathway; Stem cell/Wnt
Storage:
Storage at -20°C.
Applications:
Ibipinabant is mainly used in obesity and related metabolic disorders to help reduce body weight and improve insulin sensitivity.
